e-learning
resources
Glasgow 2004
Monday 06.09.2004
SARS and other lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chlamydia pneumoniae
persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in
chlamydia pneumoniae
-induced activation of pulmonary immune cells
D. Droemann, J. Rupp, T. Goldmann, M. Maass, D. Branscheid, P. Zabel, K. Dalhoff (Borstel, Luebeck, Großhansdorf, Germany)
Source:
Annual Congress 2004 - SARS and other lower respiratory tract infections
Session:
SARS and other lower respiratory tract infections
Session type:
Poster Discussion
Number:
1573
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Droemann, J. Rupp, T. Goldmann, M. Maass, D. Branscheid, P. Zabel, K. Dalhoff (Borstel, Luebeck, Großhansdorf, Germany).
Chlamydia pneumoniae
persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in
chlamydia pneumoniae
-induced activation of pulmonary immune cells. Eur Respir J 2004; 24: Suppl. 48, 1573
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute
C. pneumoniae
infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Chlamydia pneumoniae persists in TLR2 positive alveolar epithelial cells type II and alveolar macrophages of COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 350s
Year: 2003
Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma
Source: Eur Respir J 2008; 31: 43-46
Year: 2008
Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 730s
Year: 2005
Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease
Source: Eur Respir J 2007; 30: 736-742
Year: 2007
Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations?
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumonia
Source: Eur Respir J 2013; 41: 384-391
Year: 2013
Nontypeable Haemophilus influenzae infection of human lung tissue induces proinflammatory cytokine response via toll-like receptor 2 and EGF-receptor
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
The
moraxella catarrhalis
induced inflammatory response of pulmonary epithelial cells is mediated by activation of EGFR
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008
Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
Source: Eur Respir J 2011; 37: 53-64
Year: 2011
Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma
Source: Eur Respir J 2002; 20: 834-840
Year: 2002
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue
Source: Eur Respir J 2012; 40: 1458-1467
Year: 2012
Imbalanced secretion of IL-1β and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients
Source: Eur Respir J 2003; 22: 274-279
Year: 2003
Cigarette smoke causes increased susceptibility to respiratory pathogens: role for innate immunity toll-like receptor (TLR4) inactivation
Source: Eur Respir J 2006; 28: Suppl. 50, 853s
Year: 2006
The association between Chlamydia pneumoniae chronic infection and inflammation in COPD patients.
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
LSC 2014 abstract - Proteinase activated receptor-1 (PAR1) plays a key role in the early inflammatory response to streptococcus pneumoniae pulmonary infection
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014
The balance of pro- and anti - inflammatory cytokines in
Chlamydia pneumoniae
infected cells as a marker of inflammatory activity in the pulmonary compartment
Source: Eur Respir J 2001; 18: Suppl. 33, 154s
Year: 2001
The role of
Chlamydia pneumoniae
infection in bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 681s
Year: 2005
Role of regulatory T cells in S. pneumoniae-induced exacerbation of lung fibrosis in mice
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept